Anthropic explores IPO price hike even as equity deals slow amid hedge fund pain – ECM Pulse Global
- Hedge funds smashed by tech volatility in October
- Global ECM issuance slows as sell-off continues into November
- Anthropic IPO price hike shortsighted given fund performance
Heavy selling of tech stocks in October caused severe pain for hedge funds and, with volatility continuing apace in November, global investors are likely to show greater discernment towards capital markets opportunities before year-end.
And yet – Anthropic is reportedly looking to raise its IPO valuation above USD 1.5tn.
While markets have recovered from a sharp downturn after the US midterms – marked by the worst session for US tech stocks since Liberation Day in 2025 – the benchmark Nasdaq 100 is still 10% below its most recent high, entering correcting territory earlier this month.
The pain in October alone was certainly felt by global hedge funds. The HFRI Fund Weighted Composite Index, an equal-weighted benchmark tracking the performance of over 1,000 single-manager hedge funds, declined around 1.36% in October.
For ECM bankers, this volatility has come at an unfortunate time of the year. Because hedge funds and other investors track performance on an annual basis, many become more risk-off towards year-end anyway.
The temptation to start protecting returns rather than take on more capital markets risk consequently becomes even more attractive in a market where large multi-strategy funds have started to take a hit.
“Several hedge funds have seen a big bruise to their P&L and massive reversion of performance,” noted one ECM banker. “This means that the scale of new money funds can raise is going to be smaller and therefore the money they can put into ECM books is going to be impacted.
“We are already in November, with Thanksgiving round the corner and then it is Christmas, so the opportunities to do things are going to be much more limited.”
The scale of the pain in US markets has been felt globally, with Nigeria’s Dangote Cement postponing its London IPO last week due to market conditions around US tech stocks and emerging market equities, showing how contagion from heavy selling in one segment can spread.
Follow-on volumes across Europe have also been well below average levels in the first two weeks of November, indicating that European issuers are sitting on their hands as pain in US tech stocks continues.
October ECM volume numbers were heavily flattered by Meta’s USD 28.75bn accelerated bookbuild, alongside a USD 14.375bn convertible bond – the largest block trade and weightiest CB in history.
These two deals alone comprised more than 40% of October’s deal volume.
But the global deal count of 493 in October delivered the worst month all year in terms of global activity, showing issuers holding back from dealing as volatility began to bite.
The number of global deals was over 40% below October 2025, despite last year’s US government shutdown denting the SEC’s bandwidth. November is off to an even slower start with just 209 deals priced so far this month.
With seasonal holidays looming large, time is running out for issuers to print before year-end.
Hedge fund profit-taking could hurt Anthropic’s aftermarket
Given recent pressure, many hedge funds that do take part in block trades and other ECM transactions will be tempted to monetise positions quickly to bank alpha fast rather than hold on to stock in hopes of further profit.
“We are seeing deals with nominally good books get printed, but what we are seeing more broadly is that hedge funds seem to have next to zero duration at the moment,” said an ECM investor.
“It feels though there is no desire to take any medium to even short-term duration risk at all.”
This means that issuers that do choose to test the market with a follow-on risk a volatile aftermarket as hedge funds sell fast to bank returns.
Despite this continuing volatility, with wild moves in AI stock slowing other global ECM deals, Anthropic is on the road with a gargantuan IPO.
The timing remains perilous for the company’s equity story.
Alongside potential risks around regulation from the Democratic ascendancy in Washington, the ignominious departure of Nvidia CEO Jensen Huang – frontier AI’s most vocal champion – could lead to doubts over whether the chip behemoth’s support for model providers might wane under new management.
Some bankers speaking to ECM Pulse have always thought Anthropic’s pricing to be a relatively straightforward exercise, with fast-track index inclusion ensuring plenty of IPO demand from funds that will have to own the stock, alongside market makers ready to sell to those funds, like in the case of SpaceX.
“These mega deals don’t match the normal supply/demand dynamics of normal deals,” said one.
A hefty retail tranche should also guarantee strong demand for the IPO. The question will be how much real money is enthusiastically buying the listing, or whether many market participants just feel they need to be seen in the book.
For all of SpaceX’s idiosyncrasies, the enthusiasm for Elon Musk’s galactic infrastructure monopoly was genuine. Anthropic, as this column has written several times, is a remarkable business selling one of the best products in the history of the IPO market.
But investors feel that this is a substantially riskier buy.
Many see Anthropic as just one player in the most cutthroat and competitive industry in the world today. The company is seeing its revenue growth slow as open weight models and hyperscaler competitors capture enterprise clients, with compute costs potentially growing under a new political regime in the US.
This is why reports that Anthropic might be tempted to push its IPO price up beyond an already expensive range could be hugely short sighted.
If more bad headlines hit post-IPO and Anthropic’s stock falls below the issue price, investors that want to buy in will have to convince wounded risk managers that it is too good an opportunity not to catch a falling knife, despite the pain on the books already.
A more cautious IPO valuation that reflects this market uncertainty would seem the most prudent approach.